Ductal carcinoma in situ: state of the science and roadmap to advance the field.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Oncology

• Publication date

  2009-01-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2008.18.3103PMID 19064970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution. Commentary

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution

  2008cited by this paper
• MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.

  2007cited by this paper
• MRI for diagnosis of pure ductal carcinoma in situ : a prospective observational study. Commentary

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Ductal carcinoma in situ: correlations between high-resolution magnetic resonance imaging and histopathology

  2007cited by this paper
• Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.

  2007cited by this paper
• Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials

  2007cited by this paper
• Current treatment and clinical trial developments for ductal carcinoma in situ of the breast.

  2007cited by this paper
• Ductal carcinoma in situ in BRCA mutation carriers.

  2007cited by this paper
• Visibility of microcalcification in cone beam breast CT: effects of X-ray tube voltage and radiation dose.

  2007cited by this paper
• Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer

  2007cited by this paper
• Magnetic resonance imaging captures the biology of ductal carcinoma in situ.

  2006cited by this paper
• High‐Resolution Fluorodeoxyglucose Positron Emission Tomography with Compression (“Positron Emission Mammography”) is Highly Accurate in Depicting Primary Breast Cancer

  2006cited by this paper
• The natural history of ductal carcinoma in situ of the breast: a review

  2006cited by this paper
• Initial Outcomes for Patients Treated on the American Society of Breast Surgeons MammoSite Clinical Trial for Ductal Carcinoma-In-Situ of the Breast

  2006cited by this paper
• The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort

  2006cited by this paper
• Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

  2006cited by this paper
• Neoadjuvant hormonal therapy for ductal carcinoma in situ: Trial design and preliminary results

  2006cited by this paper
• Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid

  2006cited by this paper
• Heterogeneity of mammary lesions represent molecular differences

  2006cited by this paper
• Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer

  2006cited by this paper
• Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?

  2006cited by this paper
• Applying the neoadjuvant paradigm to ductal carcinoma in situ

  2006cited by this paper
• Computed Tomography for Imaging the Breast

  2006cited by this paper
• The receptor expression pattern in ductal carcinoma in situ predicts recurrence.

  2006cited by this paper
• Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.

  2006cited by this paper
• Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast.

  2006cited by this paper
• Cone Beam Breast CT with a Flat Panel Detector- Simulation, Implementation and Demonstration

  2005cited by this paper
• Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI

  2005cited by this paper
• Proteomic analysis of nipple aspirate fluid using SELDI‐TOF‐MS

  2005cited by this paper
• Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.

  2005cited by this paper
• Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification

  2005cited by this paper
• Evaluation of pathways for progression of heterogeneous breast tumors.

  2005cited by this paper
• Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: Results of a prospective study

  2005cited by this paper
• Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens

  2004cited by this paper
• Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ

  2004cited by this paper
• Accelerated Partial Breast Irradiation After Conservative Surgery for Breast Cancer

  2004cited by this paper
• Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ?

  2004cited by this paper
• Detection of Breast Cancer in Nipple Aspirate Fluid by CpG Island Hypermethylation

  2004cited by this paper
• Immunobiology of Her-2/Neu Transgenic Mice

  2004cited by this paper
• In situ analyses of genome instability in breast cancer

  2004cited by this paper
• Nipple-sparing mastectomy: technique and results of 54 procedures.

  2004cited by this paper
• Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2

  2004cited by this paper
• Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.

  2004cited by this paper
• Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ.

  2004cited by this paper
• Ductal lavage findings in women with known breast cancer undergoing mastectomy.

  2004cited by this paper
• Chin, K. et al. In situ analyses of genome instability in breast cancer. Nat. Genet. 36, 984−988

  2004cited by this paper
• Skin-sparing mastectomy.

  2004cited by this paper
• Gene expression profiles of human breast cancer progression

  2003cited by this paper
• Detection of chromosomal instability in paired breast surgery and ductal lavage specimens by interphase fluorescence in situ hybridization.

  2003cited by this paper
• A Comparison of Risk Perception and Psychological Morbidity in Women with Ductal Carcinoma in situ and Early Invasive Breast Cancer

  2003cited by this paper
• Oral Contraceptives and the Risk of Ductal Breast Carcinoma in situ

  2003cited by this paper
• Ductal enhancement on MR imaging of the breast.

  2003cited by this paper
• Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial.

  2003cited by this paper
• Proteomics of human breast ductal carcinoma in situ.

  2002cited by this paper
• Nipple aspirate fluid cytology in breast carcinoma

  2002cited by this paper
• Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid.

  2001cited by this paper
• Breast carcinoma in situ: risk factors and screening patterns.

  2001cited by this paper
• Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ

  2001cited by this paper
• Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.

  2000cited by this paper
• Imaging needle for optical coherence tomography.

  2000cited by this paper
• Risk factors for carcinoma in situ of the breast.

  2000cited by this paper
• Positron emission mammographic instrument: initial results.

  2000cited by this paper
• In vivo gene expression profile analysis of human breast cancer progression.

  1999cited by this paper
• Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

  1999cited by this paper
• Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

  1999cited by this paper
• Intraoperative assessment of microsurgery with three-dimensional optical coherence tomography.

  1998cited by this paper
• Laser Capture Microdissection: Molecular Analysis of Tissue

  1997cited by this paper
• In vivo endoscopic OCT imaging of precancer and cancer states of human mucosa.

  1997cited by this paper
• HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

  1997cited by this paper
• Ductal carcinoma in situ: MR imaging-histopathologic correlation.

  1995cited by this paper
• Feasibility study for positron emission mammography.

  1994cited by this paper
• Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation.

  1994cited by this paper
• Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

  1993cited by this paper
• Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype.

  1992cited by this paper
• Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

  1992cited by this paper
• Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

  1992cited by this paper
• Optical Coherence Tomography

  1991cited by this paper
• Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ.

  1990cited by this paper
• Ductal carcinoma in situ: mammographic findings and clinical implications.

  1989cited by this paper

• Deep learning-based risk stratification of ductal carcinoma in situ using mammography and abbreviated breast magnetic resonance imaging

  2025cites this paper
• Retrospective analysis in in situ ductal carcinoma; 11 years of experience

  2024cites this paper
• Interaction of de novo cholesterol biosynthesis and Hippo signaling pathway in ductal carcinoma in situ (DCIS)—comparison with the corresponding normal breast epithelium

  2023cites this paper
• Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma in situ

  2023cites this paper
• Mastectomy margins for ductal carcinoma-in-situ (DCIS): 18 Years of follow-up.

  2023cites this paper
• Intratumoral in vivo staging of breast cancer by multi-tracer PET and advanced analysis

  2022cites this paper
• miR-124-2, miR-92-A1 and miR-372 regulate differential gene expression in a mathematical model of the progression of ductal carcinoma in situ (DCIS) to microinvasive breast cancer (MIBC)

  2022cites this paper
• Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort

  2022cites this paper
• Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ

  2021cites this paper
• Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy.

  2021cites this paper
• Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma

  2021cites this paper
• 7 Image Interpretation: Noninvasive Cancer

  2021cites this paper
• The Effect of Smoking on Progression from Ductal Carcinoma In Situ to Invasive Ductal Breast Carcinoma: A Retrospective Study

  2021cites this paper
• Comparable cancer‐relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer

  2020influential citation
• Differences in pathologic characteristics between ductal carcinoma in situ (DCIS), DCIS with microinvasion and DCIS with invasive ductal carcinoma.

  2020cites this paper
• Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center.

  2020cites this paper
• Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ component

  2020cites this paper
• Multimodality Imaging of Ductal Carcinoma In Situ

  2020cites this paper
• Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast

  2020cites this paper
• Contrast-enhanced mammography in the evaluation of breast calcifications: preliminary experience

  2020cites this paper
• Ductal Carcinoma In Situ of the Breast: Perspectives on Tumor Subtype and Treatment

  2020cites this paper
• Combining the Ultrasound Features of Primary Tumor and Axillary Lymph Nodes Can Reduce False-Negative Rate during the Prediction of High Axillary Node Burden in BI-RADS Category 4 or 5 Breast Cancer Lesions.

  2020cites this paper
• Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women

  2019cites this paper
• Risk Factors as Biomarkers of Susceptibility in Breast Cancer

  2019cites this paper
• Ductal carcinoma in situ: to treat or not to treat, that is the question

  2019cites this paper
• AIB1 and ANCO1 Regulate YAP/TEAD Signaling in Early Stage Basal Breast Cancer

  2019cites this paper
• Morphologic and Molecular Features of Breast Ductal Carcinoma in Situ.

  2019cites this paper
• Towards the early detection of ductal carcinoma (a common type of breast cancer) using biomarkers linked to the PPAR(γ) signaling pathway

  2019cites this paper
• Quality of DCIS information on the internet: a content analysis

  2019cites this paper
• Breast tumor localization using skin surface temperatures from a 2D anatomic model without knowledge of the thermophysical properties

  2019cites this paper
• Abnormal Screening Mammogram

  2019cites this paper
• The prognostic significance of co-existence ductal carcinoma in situ in invasive ductal breast cancer: a large population-based study and a matched case-control analysis.

  2019cites this paper
• Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression

  2019cites this paper
• Skin diseases of the breast and nipple: Benign and malignant tumors.

  2019cites this paper
• Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes

  2019cites this paper
• NATURAL HISTORY OF DUCTAL CARCINOMA IN SITU História natural do carcinoma ductal in situ

  2018cites this paper
• Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation

  2018cites this paper
• The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ

  2018cites this paper
• Navigating treatment controversies for DCIS in the era of genomic profiling and active surveillance trials.

  2018cites this paper
• Ductal carcinoma in situ of the breast - Long term results from a twenty-year cohort.

  2018cites this paper
• Natural history of ductal carcinoma in situ

  2018cites this paper
• The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast

  2018cites this paper
• Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification

  2018cites this paper
• Chapter 4 Early-Stage Progression of Breast Cancer

  2018cites this paper
• Epidemiology and Risk Factors

  2018cites this paper
• Current controversies in radiotherapy for breast cancer

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Finding the balance between overtreatment and undertreatment of ductal carcinoma in situ

  2017cites this paper
• Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial

  2017cites this paper
• Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study

  2017cites this paper
• Early-Stage Progression of Breast Cancer

  2017cites this paper
• Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update

  2017cites this paper
• Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).

  2017cites this paper
• Histological, immunohistological and molecular characteristics of intraductal precursor of carcinoma ex pleomorphic adenoma support a multistep carcinogenic process

  2017cites this paper
• Differentiation of ductal carcinoma in situ versus fibrocystic changes by magnetic resonance imaging: are there pathognomonic imaging features?

  2017cites this paper
• DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes

  2017influential citation
• Prioritizing Mental Health Research in Cancer Patients and Survivors.

  2017cites this paper
• Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?

  2017cites this paper
• Finding the balance between overtreatment and undertreatment of ductal carcinoma in situ

  2017cites this paper
• Controversies and Clinical Trials for DCIS: Margins and Active Surveillance

  2017cites this paper
• DCIS and axillary nodal evaluation: compliance with national guidelines

  2017cites this paper
• CD8+ tumor‐infiltrating lymphocytes contribute to spontaneous “healing” in HER2‐positive ductal carcinoma in situ

  2016cites this paper
• The Clinical and Histopathological Significance of Performing Surgical Cavity Random Biopsy in Breast Conserving Surgery on Disease Course and LocalRecurrence

  2016cites this paper
• Sensitivity of breast MRI for ductal carcinoma in situ appearing as microcalcifications only on mammography.

  2016cites this paper
• Ductal Carcinoma In Situ

  2016cites this paper
• Loss of Rap1Gap: A driver in the progression from DCIS of the breast to IDC

  2016cites this paper
• Breast carcinoma in situ: An observational study of tumor subtype, treatment and outcomes

  2016cites this paper
• Non-mass lesions on screening breast ultrasound.

  2016cites this paper
• Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.

  2016cites this paper
• Factores predictivos de malignidad en microcalcificaciones de mama sin lesiones

  2016cites this paper
• Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence

  2016cites this paper
• The Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative Biopsy

  2016cites this paper
• Pathology of healing: what else might we look at?

  2016cites this paper
• Two progressive pathways of microinvasive carcinoma: low-grade luminal pathway and high-grade HER2 pathway based on high tumour-infiltrating lymphocytes

  2016cites this paper
• Final results from a multicenter prospective study ( JROSG 05–5) on postoperative radiotherapy for patients with ductal carcinoma in situ with an involved surgical margin or close margin widths of 1 mm or less

  2015cites this paper
• Current management of lesions associated with an increased risk of breast cancer

  2015cites this paper
• Ductal Carcinoma In Situ: Treatment Update and Current Trends

  2015cites this paper
• Sonographic Features of Ductal Carcinoma In Situ of the Breast With Microinvasion

  2015cites this paper
• Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.

  2015cites this paper
• Complete Regression of Ductal Carcinoma in Situ Following Chemotherapy and Trastuzumab: Should we Rethink Management?

  2015cites this paper
• Identifying three different architectural subtypes of mammary ductal carcinoma in situ using multiphoton microscopy

  2015cites this paper
• Correlation between sonographic findings and clinicopathologic and biologic features of pure ductal carcinoma in situ in 691 patients.

  2015cites this paper
• Morphologic, molecular and microenvironment factors associated with stromal invasion in breast ductal carcinoma in situ: Role of myoepithelial cells.

  2015cites this paper
• Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.

  2015cites this paper
• Extent and Role of Margin Control for DCIS Managed by Breast-Conserving Surgery

  2015cites this paper
• Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative

  2015cites this paper
• The locoregional recurrence post-mastectomy for ductal carcinoma in situ: Incidence and risk factors.

  2015cites this paper
• Staging of Breast Cancer

  2015cites this paper
• Ductal carcinoma in situ: treatment or active surveillance?

  2015cites this paper
• A Case of Neuroendocrine Ductal Carcinoma in situ Presenting with Elevated Serum Levels of Carcinoembryonic Antigen (CEA)

  2015cites this paper
• The CCL5-CCR5 Axis in Breast Cancer

  2015cites this paper
• When is good enough really good enough? Defining the role of radiation in low-risk ductal carcinoma in situ.

  2015cites this paper
• High-resolution 3D micro-CT imaging of breast microcalcifications: a preliminary analysis

  2014cites this paper
• Identifying a Highly-Aggressive DCIS Subgroup by Studying Intra-Individual DCIS Heterogeneity among Invasive Breast Cancer Patients

  2014cites this paper
• Comparing methods for modelling spreading cell fronts.

  2014cites this paper
• Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.

  2014cites this paper
• Underestimation of invasive lesions in patients with ductal carcinoma in situ of the breast diagnosed by ultrasound-guided biopsy: a comparison between patients with and without HER2/neu overexpression.

  2014cites this paper
• Oxidative stress in breast and gynaecological carcinogenesis

  2014cites this paper
• Fatores morfológicos, moleculares e do microambiente relacionados ao risco de invasão estromal em carcinomas ductais in situ da mama

  2014cites this paper
• Pathology and Biological Markers of Invasive Breast Cancer

  2014cites this paper
• Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.

  2014cites this paper